The Maudsley Prescribing Guidelines
Seiten
2024
|
15. Auflage
Wiley-Blackwell (Verlag)
978-1-394-23876-7 (ISBN)
Wiley-Blackwell (Verlag)
978-1-394-23876-7 (ISBN)
- Noch nicht erschienen (ca. April 2025)
- Versandkostenfrei
- Auch auf Rechnung
- Artikel merken
Discover the essential evidence-based handbook on the safe and effective prescribing of psychotropic agents in this comprehensive resource
Prescribing medications for patients suffering from mental illness is a challenging but essential component of clinical practice. Drug choice, dosage, and other considerations can have a critical impact on patient outcomes and long-term care. For years, The »Maudsley Prescribing Guidelines« have served as the indispensable evidence-based handbook for prescribing psychotropic medications. Now fully updated to reflect the latest evidence and practice, it will continue to serve a new generation of trainees and clinicians.
Readers of the fifteenth edition of The Maudsley Prescribing Guidelines will also find:
»The Maudsley Prescribing Guidelines« is ideal for trainees looking to gain essential information on the rational, safe, and effective use of medications for patients with mental illness. Experienced clinicians will also find guidance on complex issues that they may not encounter regularly.
Prescribing medications for patients suffering from mental illness is a challenging but essential component of clinical practice. Drug choice, dosage, and other considerations can have a critical impact on patient outcomes and long-term care. For years, The »Maudsley Prescribing Guidelines« have served as the indispensable evidence-based handbook for prescribing psychotropic medications. Now fully updated to reflect the latest evidence and practice, it will continue to serve a new generation of trainees and clinicians.
Readers of the fifteenth edition of The Maudsley Prescribing Guidelines will also find:
- Analysis of all psychotropic drugs currently used in the US, UKA, Canada, Australia, New Zealand, and Japan
- Detailed discussion of topics including adverse effects, the ramifications of switching medication, special patient groups, and many more
- Fully up-to-date reference lists at the end of each chapter
»The Maudsley Prescribing Guidelines« is ideal for trainees looking to gain essential information on the rational, safe, and effective use of medications for patients with mental illness. Experienced clinicians will also find guidance on complex issues that they may not encounter regularly.
David Taylor, PhD, FFRPS, FRPharmS, FRCPEdin, FRCPsych(Hon), is Director of Pharmacy and Pathology at the South London and Maudsley NHS Trust and Professor of Psychopharmacology at King's College, London. He is the lead author of the Maudsley Prescribing Guidelines in Psychiatry and Editor-in-Chief of Therapeutic Advances in Psychopharmacology. He co-authored the Royal College of Psychiatrists guide on 'Stopping antidepressants'. His pharmacy department ran a medication help-line for a decade which fielded queries largely related to withdrawal from psychiatric drugs. He has personal experience of stopping psychiatric drugs.
| Erscheint lt. Verlag | 24.4.2025 |
|---|---|
| Reihe/Serie | The Maudsley Prescribing Guidelines Series |
| Sprache | englisch |
| Einbandart | kartoniert |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
| Schlagworte | Psychopharmaka |
| ISBN-10 | 1-394-23876-2 / 1394238762 |
| ISBN-13 | 978-1-394-23876-7 / 9781394238767 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Arzneimittelverzeichnis für Deutschland (einschließlich …
Buch | Hardcover (2024)
Rote Liste Service GmbH (Verlag)
CHF 149,95
Englisch für Apotheker und PTAs
Buch | Spiralbindung (2024)
Kohlhammer (Verlag)
CHF 44,75
